Ignite Creation Date:
2024-05-05 @ 11:39 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00104117
Status:
COMPLETED
Last Update Posted:
2010-02-19
First Post:
2005-02-23
Brief Title:
Study of XL999 in Adults With Solid Tumors
Sponsor:
Symphony Evolution Inc
Organization:
Symphony Evolution Inc
Study Overview
Official Title:
A Phase 1 Dose Escalation Study of the Safety Pharmacokinetics and Pharmacodynamics of XL999 Administered Intravenously to Subjects With Solid Tumors
Status:
COMPLETED
Status Verified Date:
2010-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess the safety and tolerability of XL999 in adults with advanced solid tumors
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None